Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ALB NYSE:ARC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALBAlbemarle$71.00+1.1%$60.41$49.43▼$113.91$8.35B1.632.88 million shs4.02 million shsARCARC Document Solutions$3.39$3.39$2.87▼$3.44$146.65M1.13284,189 shsN/AInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALBAlbemarle+7.05%+11.66%+17.24%+15.81%-29.25%ARCARC Document Solutions0.00%0.00%0.00%0.00%+16.30%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALBAlbemarle4.2281 of 5 stars4.11.02.50.63.61.70.6ARCARC Document SolutionsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALBAlbemarle 2.14Hold$91.6229.04% UpsideARCARC Document Solutions 4.00Strong BuyN/AN/ACurrent Analyst Ratings BreakdownLatest RTOP, ARC, ALB, and S247 Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/14/2025ALBAlbemarlePiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetUnderweight ➝ Underweight$68.005/6/2025ALBAlbemarleScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector Perform ➝ Sector Perform$75.00 ➝ $65.005/6/2025ALBAlbemarleJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$80.00 ➝ $60.005/6/2025ALBAlbemarleMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetUnderweight ➝ Underweight$68.00 ➝ $58.005/2/2025ALBAlbemarleKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$102.00 ➝ $95.005/1/2025ALBAlbemarleTD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$115.00 ➝ $65.004/15/2025ALBAlbemarleCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$85.00 ➝ $64.004/15/2025ALBAlbemarleRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$77.00 ➝ $60.004/14/2025ALBAlbemarleKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$122.00 ➝ $102.004/14/2025ALBAlbemarleTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$85.00 ➝ $65.00(Data available from 7/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALBAlbemarle$5.38B1.55$4.15 per share17.11$67.76 per share1.05ARCARC Document Solutions$281.20M0.52$0.69 per share4.94$3.62 per share0.94Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALBAlbemarle-$1.18B-$11.12N/A37.17N/A-22.39%-1.92%-0.92%7/30/2025 (Estimated)ARCARC Document Solutions$8.23M$0.1130.8216.141.531.61%5.28%2.66%N/ALatest RTOP, ARC, ALB, and S247 EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2025Q2 2025ALBAlbemarle-$0.76N/AN/AN/A$1.23 billionN/A4/30/2025Q1 2025ALBAlbemarle-$0.62-$0.18+$0.44N/A$1.18 billion$1.08 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALBAlbemarle$1.622.28%N/AN/A 30 YearsARCARC Document Solutions$0.205.90%N/A181.83%N/ALatest RTOP, ARC, ALB, and S247 DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/6/2025ALBAlbemarlequarterly$0.40502.82%6/13/20256/13/20257/1/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALBAlbemarle0.392.111.26ARCARC Document Solutions0.331.491.37Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALBAlbemarle92.87%ARCARC Document Solutions48.93%Insider OwnershipCompanyInsider OwnershipALBAlbemarle0.33%ARCARC Document Solutions18.79%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALBAlbemarle8,300117.66 million117.27 millionOptionableARCARC Document Solutions1,90043.26 million35.13 millionOptionableRTOP, ARC, ALB, and S247 HeadlinesRecent News About These CompaniesONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark ApplicationJuly 1, 2025 | globenewswire.comONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025June 17, 2025 | globenewswire.comARC Resources: Double First Quarter Boost Thanks To The Attachie ProjectMay 2, 2025 | seekingalpha.comExploring AI in Healthcare Facilities: David Trask, National Director at ARC Facilities, to Present Educational Session at TAHFM ConferenceApril 3, 2025 | finance.yahoo.comExploring AI in Healthcare Facilities: David Trask, National Director at ARC Facilities, to ...April 3, 2025 | gurufocus.comARC Facilities Unveils Partner Program to Expand Facility Management Industry ReachMarch 26, 2025 | finance.yahoo.comONWARD Medical Announces First-in-Human Use of ARC-IM Lumbar Lead Designed to Restore Standing, Stepping, and Lower Limb MobilityMarch 26, 2025 | globenewswire.comARC Document Solutions: ARC Facilities Unveils Partner Program to Expand Facility Management Industry ReachMarch 24, 2025 | finanznachrichten.deMETAVISIO – THOMSON Computing : ARC Group launches Phase 2 of the U.S. Listing ProcessMarch 21, 2025 | accessnewswire.comAThe Association of Related Churches Unveils Special Guests and Speakers for ARC Conference 2025March 13, 2025 | businesswire.comARC Document Solutions: ARC Facilities Elevates AI-Powered Platform with New EnhancementsMarch 10, 2025 | finanznachrichten.deARC Facilities Elevates AI-Powered Platform with New EnhancementsMarch 10, 2025 | gurufocus.comARC Resources: Three Pillars Of Growth Driving Free Cash Flow Yield Into High-TeensFebruary 10, 2025 | seekingalpha.comIs Deluxe Corporation a Stock Worth Watching?February 3, 2025 | stocknews.comONWARD Medical Announces First Commercial Sales of ARC-EX SystemJanuary 9, 2025 | globenewswire.comDino Rizzo Celebrates Landmark Growth for ARC Churches in 2024December 30, 2024 | businesswire.comThe Association of Related Churches Reflects on a Powerful Gather 2024 ConferenceDecember 17, 2024 | businesswire.comArc Gateway to end ShredWorks work initiative at end of yearDecember 6, 2024 | msn.comARC Document Solutions completes merger and credit agreementNovember 24, 2024 | uk.investing.comONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after StrokeNovember 19, 2024 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Catalysts in 7 Days: Archer's Growth Story Just AcceleratedBy Jeffrey Neal Johnson | June 18, 2025View 3 Catalysts in 7 Days: Archer's Growth Story Just AcceleratedGovernment Mandate Sends eVTOL Stocks FlyingBy Jeffrey Neal Johnson | June 10, 2025View Government Mandate Sends eVTOL Stocks Flying3 Growth Stocks Too Small for Institutions to BuyBy Gabriel Osorio-Mazilli | June 19, 2025View 3 Growth Stocks Too Small for Institutions to BuyUPS Is Outpacing the Market: A Green Light for Investors?By Jeffrey Neal Johnson | June 27, 2025View UPS Is Outpacing the Market: A Green Light for Investors?As Gold Surges, Albemarle Stock May Be the Next to PopBy Gabriel Osorio-Mazilli | June 10, 2025View As Gold Surges, Albemarle Stock May Be the Next to PopRTOP, ARC, ALB, and S247 Company DescriptionsAlbemarle NYSE:ALB$71.00 +0.78 (+1.11%) Closing price 03:56 PM EasternExtended Trading$71.25 +0.25 (+0.35%) As of 05:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Specialties segment provides bromine-based specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; develops and manufactures cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. The Ketjen segment offers clean fuels technologies (CFT), which is composed of hydroprocessing catalysts (HPC) together with isomerization and akylation catalysts; fluidized catalytic cracking (FCC) catalysts and additives; and performance catalyst solutions (PCS), which is composed of organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.ARC Document Solutions NYSE:ARCARC Document Solutions, Inc., a digital printing company, provides digital printing and document-related services in the United States. It provides managed print services, that places, manages, and optimizes print and imaging equipment in customers' offices, job sites, and other facilities; and cloud-based document management software and other digital hosting services. The company also provides professional services and software services to re-produce and distribute large-format and small-format documents, and specialized graphic color printing. In addition, it engages in the sale and supply of equipment; and provides ancillary services. The company operates service centers in the United States, Canada, China, the United Kingdom, India, and the United Arab Emirates. It serves local restaurant owners, construction subcontractors, international retailers, regional energy companies, and largest school districts, as well as retail, technology, energy, education, hospitality, public utilities, and others. The company was formerly known as American Reprographics Company and changed its name to ARC Document Solutions, Inc. in 2012. ARC Document Solutions, Inc. was founded in 1988 is headquartered in San Ramon, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla Stock Could Accelerate on New EV Tax Legislation SoundHound Rises as Short Sellers Exit and AI Demand Grows Why Marvell Could Be the Smartest AI Bet Under $80 Autodesk Stock Ready to Rip? Q3 May Be the Turning Point Amazon's Prime Day Pullback Meets Bullish Golden Cross Signal Palantir’s Revenue Surge to $1B: Growth vs. Valuation Chime Financial: Analysts Ring In—And It’s a Buy Is Fortinet Ready to Break Out After Months of Consolidation? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
